title: Macrophage-directed immunotherapy as adjuvant to photodynamic therapy of cancer.
abstract: The effect of Photofrin-based photodynamic therapy (PDT) and adjuvant treatment with serum vitamin D3-binding protein-derived macrophage-activating factor (DBPMAF) was examined using a mouse SCCVII tumour model (squamous cell carcinoma). The results show that DBPMAF can markedly enhance the curative effect of PDT. The most effective DBPMAF therapy consisted of a combination of intraperitoneal and peritumoral injections (50 and 0.5 ng kg-1 respectively) administered on days 0, 4, 8 and 12 after PDT. Used with a PDT treatment curative to 25% of the treated tumours, this DBPMAF regimen boosted the cures to 100%. The DBPMAF therapy alone showed no notable effect on the growth of SCCVII tumour. The PDT-induced immunosuppression, assessed by the evaluation of delayed-type contact hypersensitivity response in treated mice, was greatly reduced with the combined DBPMAF treatment. These observations suggest that the activation of macrophages in PDT-treated mice by adjuvant immunotherapy has a synergistic effect on tumour cures. As PDT not only reduces tumour burden but also induces inflammation, it is proposed that recruitment of the activated macrophages to the inflamed tumour lesions is the major factor for the complete eradication of tumours.
authors.affiliation: Cancer Imaging, British Columbia Cancer Agency, Vancouver, Canada.
authors.forename: M
authors.initials: M
authors.lastname: Korbelik
authors.forename: V R
authors.initials: VR
authors.lastname: Naraparaju
authors.forename: N
authors.initials: N
authors.lastname: Yamamoto
mesh_terms: D000276:Adjuvants, Immunologic; D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D003131:Combined Modality Therapy; D006968:Hypersensitivity, Delayed; D007165:Immunosuppression Therapy; D007167:Immunotherapy; D008262:Macrophage Activation; D016215:Macrophage-Activating Factors / Q000008:administration & dosage*; D008264:Macrophages / Q000276:immunology*; D051379:Mice; D008809:Mice, Inbred C3H; D010778:Photochemotherapy / Q000379:methods*; D014809:Vitamin D-Binding Protein / Q000008:administration & dosage*
chemical_list: D000276:Adjuvants, Immunologic; D016215:Macrophage-Activating Factors; D014809:Vitamin D-Binding Protein; C101908:vitamin D-binding protein-macrophage activating factor